id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2015-N-2002-0008,FDA,FDA-2015-N-2002,"Clarification of When Products Made or Derived From Tobacco Are
Regulated as Drugs, Devices, or Combination Products; Amendments
to Regulations Regarding ‘‘Intended Uses’’; Reopening of the Comment
Period",Proposed Rule,Reopening of Comment Period,2015-11-30T05:00:00Z,2015,11,2015-11-30T05:00:00Z,2015-12-31T04:59:59Z,2015-12-31T22:00:26Z,2015-30271,0,0,0900006481d7964a
FDA-2015-N-2002-0002,FDA,FDA-2015-N-2002,"List of References re Clarification of When Products Made or Derived From Tobacco Are Regulated as Drugs, Devices or Combination Products Amendments to Regulations Regarding Intended Uses Proposed Rule",Supporting & Related Material,Background Material,2015-09-25T04:00:00Z,2015,9,,,2015-12-03T12:44:54Z,,0,0,0900006481c965b1
FDA-2015-N-2002-0003,FDA,FDA-2015-N-2002,"Reference 1 - U.S. Dept of Commerce, Bureau of Economic Analysis Natiuonal Income and Product Accounts",Supporting & Related Material,Background Material,2015-09-25T04:00:00Z,2015,9,,,2015-12-03T12:45:11Z,,0,0,0900006481c965b2
FDA-2015-N-2002-0005,FDA,FDA-2015-N-2002,"Reference 3 - Easley, David, and OHara - Ambiguity and Nonparticipation, The Role of Regulation- Review of Financial Studies",Supporting & Related Material,Background Material,2015-09-25T04:00:00Z,2015,9,,,2015-12-03T12:45:51Z,,0,0,0900006481c965b4
FDA-2015-N-2002-0001,FDA,FDA-2015-N-2002,"Clarification of When Products Made or Derived From Tobacco Are 
Regulated as Drugs, Devices, or Combination Products; Amendments to 
Regulations Regarding ``Intended Uses''",Proposed Rule,Notice of Proposed Rulemaking (NPRM),2015-09-25T04:00:00Z,2015,9,2015-09-25T04:00:00Z,2015-11-25T04:59:59Z,2016-01-15T22:00:58Z,2015-24313,0,0,0900006481c95e75
FDA-2015-N-2002-0004,FDA,FDA-2015-N-2002,"Reference 2 - Ellsberg, Daniel -Risk, Ambiguity, and the Savage Axioms- The Quarterly Journal of Economics",Supporting & Related Material,Background Material,2015-09-25T04:00:00Z,2015,9,,,2015-12-03T12:45:34Z,,0,0,0900006481c965b3
FDA-2015-N-2002-0006,FDA,FDA-2015-N-2002,"Reference 4 - Dimmock et al - Ambiguity Aversion and Household Portfolio Choice, Empirical Evidence- NBER Working Paper Series",Supporting & Related Material,Background Material,2015-09-25T04:00:00Z,2015,9,,,2015-12-03T12:46:10Z,,0,0,0900006481c9622e
FDA-2015-N-2002-0007,FDA,FDA-2015-N-2002,"Reference 5 - Defendant's Memorandum of Points and Authorities in Support of Motion to Dismiss or Summary Judgment, Allergan Inc., v. U.S.",Supporting & Related Material,Background Material,2015-09-25T04:00:00Z,2015,9,,,2015-12-03T12:46:32Z,,0,0,0900006481c9622f